Trulance® Safety Adult patients with CIC and IBS-C. ISI below.

Peer-reviewed data

Clinical publications and presentations

Evidence supporting TRULANCE® and our GC-C research programs.

Highlights

Key focus areas

Efficacy outcomes

Clinical studies evaluating symptom relief and bowel function in adults with CIC and IBS-C.

Safety monitoring

Adverse event profiles with emphasis on diarrhea and contraindications.

Mechanistic insights

Publications detailing GC-C agonist mechanisms and translational science.

Access publications: For reprints or media inquiries, contact info@synergycures.com. Full prescribing and Important Safety Information remain available below.